These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3277421)

  • 21. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Arterial hypertension, renal function and angiotensin-converting enzyme inhibition].
    Ribstein J; Mourad G; Mimran A
    Presse Med; 1988 Sep; 17(31):1578-82. PubMed ID: 2971959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Unnoticed loss of renal function during treatment with angiotensin I converting enzyme inhibitor. A new risk in patients with unrecognized unilateral stenosis of the renal artery].
    Tingleff J; Strandgaard S
    Ugeskr Laeger; 1989 Nov; 151(45):2958-60. PubMed ID: 2588387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Converting enzyme inhibitors and renal function in essential and renovascular hypertension.
    Mimran A; Ribstein J; DuCailar G
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):7S-14S. PubMed ID: 2009153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible renal impairment induced by treatment with the angiotensin II receptor antagonist candesartan in a patient with bilateral renal artery stenosis.
    Johansen TL; Kjaer A
    BMC Nephrol; 2001 May; 2():1. PubMed ID: 11388887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of kidney in hypertension.
    Tripathi S; Tripathi K
    J Indian Med Assoc; 2003 Apr; 101(4):260-2, 264-5. PubMed ID: 12964647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension in kidney transplant recipients.
    Ponticelli C; Cucchiari D; Graziani G
    Transpl Int; 2011 Jun; 24(6):523-33. PubMed ID: 21382101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bilateral renal artery stenosis--a cause of acute pulmonary edema].
    Høieggen A; Draganov B; Os I
    Tidsskr Nor Laegeforen; 2001 Jun; 121(15):1789-90. PubMed ID: 11464682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.
    Hollenberg NK; Swartz SL; Passan DR; Williams GH
    N Engl J Med; 1979 Jul; 301(1):9-12. PubMed ID: 221809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy.
    Hollenberg NK; Raij L
    Arch Intern Med; 1993 Nov; 153(21):2426-35. PubMed ID: 8215747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modification of renal hemodynamics and proteinuria in patients with arterial hypertension and kidney diseases].
    Risler T; Erley CM
    Z Kardiol; 1993; 82 Suppl 4():39-44. PubMed ID: 7908476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure and renal outcomes in patients with kidney infarction and hypertension.
    Paris B; Bobrie G; Rossignol P; Le Coz S; Chedid A; Plouin PF
    J Hypertens; 2006 Aug; 24(8):1649-54. PubMed ID: 16877969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system.
    Humke U; Levens N; Wood J; Hofbauer K
    J Pharmacol Exp Ther; 1992 Jan; 260(1):29-35. PubMed ID: 1309874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The long-term effects of a new converting enzyme inhibitor, delapril hydrochloride, on renal function, renin-angiotensin-aldosterone system and kallikrein-kinin prostaglandin system in hypertensive patients].
    Nishiyama K; Igari T; Nanba S; Ishii M
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):801-7. PubMed ID: 2273596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of angiotensin converting enzyme inhibition on effective renal plasma flow in patients with diffuse renal parenchymal diseases and hypertension.
    Zeravica R; Stosić Z; Ilincić B; Crnobrnja V; Jakovljević A; Mijović R
    Med Pregl; 2014; 67(3-4):78-82. PubMed ID: 24961048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute failure of transplanted kidney after administration of angiotensin converting enzyme inhibitors (iACE)].
    Rell K; Serafinowicz A; Gaciong Z; Michnowska M; Lao M
    Pol Arch Med Wewn; 1993 May; 89(5):405-9. PubMed ID: 8367375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olmesartan associated with acute renal failure in a patient with bilateral renal artery stenosis.
    Bavbek N; Kasapoglu B; Isik A; Kargili A; Kirbas I; Akcay A
    Ren Fail; 2010; 32(9):1115-7. PubMed ID: 20863218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Renal function during treatment with angiotensin converting enzyme inhibitors].
    Rasmussen K; Heitmann M; Nielsen JI; Møgelvang JC
    Ugeskr Laeger; 1995 Sep; 157(39):5377-81. PubMed ID: 7483049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.